Fujiyama Power Systems Limited moves to reshape its capital structure

The maximum potential dilution cannot be quantified because the board-approved QIP limit and the number of shares in the new ESOP allotment are not reported in the available filing/news evidence.

The company’s current paid-up equity share capital is Rs 30.69 Crores for Q1 FY27 ^[1]. With a face value of Rs 1 per share, this corresponds to approximately 30.69 Crore existing shares.

Required calculation:

• Aggregate new shares = QIP shares + ESOP-allotted shares
• Maximum dilution to the existing base = aggregate new shares ÷ 30.69 Crore × 100
• Post-issue paid-up capital = Rs 30.69 Crores + the nominal value of the aggregate new shares

Accordingly, the comparison to current paid-up capital remains not determinable until the QIP limit is provided in shares or rupees and the ESOP allotment is provided in shares.

The board resolution does not state a debt-reduction versus working-capital split for the QIP proceeds. Its stated object is to raise up to Rs 1,200 Crores to achieve and maintain the company’s minimum public-shareholding requirement ^[2]. The securities-issuance annexure confirms the maximum issue size but does not provide a use-of-proceeds allocation ^[3].

Leverage profile

The latest reported standalone metrics for Q1 FY27 show:

• Total debt: Rs 461.48 Crores ^[4]
• Net debt: Rs 322.02 Crores, after Rs 139.46 Crores of cash and equivalents ^{[5] [6]}
• Gross debt/equity: 0.36x ^[7]
• Net debt/equity: 0.25x ^[8]
• Net debt/EBITDA: 1.25x ^[9]

Analyst read: this is a meaningful but not highly stretched leverage position. Debt reduction would therefore be financially coherent and would lower interest and refinancing risk, but it is not identified as the stated QIP purpose in the board filing. Conversely, the filing does not establish that any defined portion will fund working capital. The defensible conclusion is that the QIP is presently a public-shareholding compliance transaction, with the debt-repayment and working-capital proportions not separately disclosed.

The 4,11,587-share allotment cannot be compared with a historical annual grant run-rate from the disclosed information, and it does not by itself support an incremental P&L charge for the upcoming fiscal year. The filing describes shares issued to employees upon exercise of ESOP 2023 options, rather than a fresh grant quantified with grant-date fair value and vesting terms ^[10].

• Quantum: 4,11,587 shares were allotted at an exercise price of Rs 398.39 per share ^[10].
• Dilution: This represents approximately 0.13% of post-allotment equity, derived from 4,11,587 shares and 30,73,13,349 post-issue shares ^[10].
• Historical comparison: The filing does not provide the company’s prior-year ESOP grant quantities, so an annual grant run-rate or multiple of run-rate cannot be calculated.
• Cash proceeds: The exercise price implies proceeds of approximately Rs 16.40 Crores, derived from 4,11,587 × Rs 398.39. This is an equity issuance inflow, not employee benefit expense.

P&L impact

The incremental employee benefit expense for the upcoming fiscal year is not quantifiable from this allotment notice. The required inputs—grant-date fair value, vesting period, number of options originally granted, unvested options, and any expense already recognized—are not disclosed in the filing.

The key accounting distinction is that an exercise/allotment event is not the same as a new grant event. Therefore, the 4,11,587 shares should not be added mechanically to the employee cost line. For scale, reported consolidated employee cost was Rs 38.94 Crores in Q1 FY27 ^[11], but the ESOP-related component is not separately identified.

Analytical conclusion: the allotment is immaterial from a share-count perspective at roughly 0.13% dilution. Unless the company separately discloses a new grant or a catch-up charge, the allotment notice alone does not indicate a measurable step-up in employee benefit expense in the next fiscal year.